Relapsed data are uncompetitive, but the front-line PACC-mutant space offers hope.
ApexOnco Front Page
Recent articles
Though lung cancer looks promising a partner is now needed.
Multispecifics newly into the clinic include Car-Ts from Essen and Unicar.
ESO-T01 delivers its first four multiple myeloma case reports.
The company, apparently unbothered by Enhertu, is starting a new HER2 x HER2 phase 3.
PD-(L)1 x VEGF bispecifics prove a big draw.
The Tang Capital Partners vehicle has already acquired IGM, Elevation and Kronos.
ADCs newly into human trials include Lilly's PTK7 and two bispecifics.
